New non-validated practice : an enhanced definition of innovative practice for medicine [Separata] /

A significant part of the literature on innovative practice in medicine relates to seizing opportunities and curbing harms for patients in desperate situations. Unfortunately, the term innovation has multiple meanings and a rich rhetorical flourish that adds confusion and misunderstanding to an alre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mastroleo, Ignacio (Autor), Holzer, Felicitas (Autor)
Formato: Capítulo de libro
Lenguaje:Inglés
Materias:
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 02102naa a2200277 a 4500
003 AR-BaFLA
005 20211101152121.0
008 191113t2020 -uk |||fs2||| 000 0 eng d
040 |a FLACSO Argentina  |c FLACSO Argentina  |b spa  |e rda 
041 0 |a eng 
100 1 |9 19323  |a Mastroleo, Ignacio  |e aut. 
245 1 0 |a New non-validated practice :   |b an enhanced definition of innovative practice for medicine [Separata] /   |c Ignacio Mastroleo and Felicitas Holzera  |h DIG 
300 |a pp. 1-29 
336 |2 rdacontent  |a Texto  |b txt 
337 |2 rdamedia  |a computadora  |b c 
338 |2 rdacarrier  |a Recurso el línea  |b cr 
504 |a incl. ref. 
520 |a A significant part of the literature on innovative practice in medicine relates to seizing opportunities and curbing harms for patients in desperate situations. Unfortunately, the term innovation has multiple meanings and a rich rhetorical flourish that adds confusion and misunderstanding to an already difficult debate. This paper aims to enhance the current definition of innovative practice for medicine. First, we replace the term ‘innovation’ with the more literal ‘new non-validated practice’. To identify this meaning, we analyse the traditional research ethics’ distinction between research, validated practice, and innovation in the Belmont Report. Second, we propose the following explicit definition of new non-validated practice: the first or recent use of diagnostic, therapeutic or preventive interventions that introduce a significant change, with an insufficient level of evidence of safety or efficacy for regular healthcare, and with the main aim to benefit individual patients. This definition is a promising conceptual tool to inform empirical research, ethicists, and the harmonisation of regulation and legislation (e.g. right-to-try laws). 
650 4 |9 6439  |a MEDICINA 
650 4 |9 3806  |a INNOVACIONES 
650 4 |9 2962  |a BIOETICA 
690 |a SALUD 
700 1 |9 33576  |a Holzer, Felicitas  |e aut. 
773 |d London : Taylor & Francis, 2020  |t Law, innovation and technology  |x 1757-997X 
942 |c ART 
999 |c 48358  |d 48358